Low dose of BIIL 284 BS tablets

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Arthritis, RheumatoidPulmonary Disease, Chronic Obstructive

Phase 1

Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

CompletedNCT02247375

Boehringer IngelheimArthritis, Rheumatoid

Start: 2000-01-31Updated: 2014-09-25

Phase 2

Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT02249247

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2001-04-30Updated: 2014-09-26